Impact of Covid-19 in the Emergency Department
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey
- Status
- SUSPENDED
- Phase
- PHASE2
Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients
- Status
- UNKNOWN
- Phase
- N/A
Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19
- Status
- COMPLETED
- Phase
- NA
Assessment of Sexual Dysfunction Among COVID-19 Recovered Patients
- Status
- UNKNOWN
- Phase
- N/A
The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting
- Status
- UNKNOWN
- Phase
- N/A
SARS CoV-2 Infection and Inflammatory Biomarkers
- Status
- COMPLETED
- Phase
- N/A
Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus Infection
- Status
- COMPLETED
- Phase
- NA
Cognitive Assessment in COVID-19 Positive Patients Using the DANA App
- Status
- COMPLETED
- Phase
- N/A
Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection
- Status
- COMPLETED
- Phase
- N/A
Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)
- Status
- COMPLETED
- Phase
- PHASE2
Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy
- Status
- TERMINATED
- Phase
- N/A
Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]
- Status
- COMPLETED
- Phase
- PHASE4